BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12687160)

  • 1. Immunohistochemical Investigation of the Heart Allograft Myocardium (1991-1998).
    Beletskaya LV; Baranova FS; Khalimova ZA; Zaidenov VA; Kurenkova LG; Kormer AY; Khubutia AS; Kupriyanova AG; Shumakov VI
    Russ J Immunol; 2000 Apr; 5(1):33-38. PubMed ID: 12687160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.
    Hammond EH; Yowell RL; Nunoda S; Menlove RL; Renlund DG; Bristow MR; Gay WA; Jones KW; O'Connell JB
    J Heart Transplant; 1989; 8(6):430-43. PubMed ID: 2693662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Humoral immunopathologic changes in the myocardium after clinical allotransplantation of the heart].
    Beletskaia LV; Baranova FS; Khalimova ZA; Kurenkova LG; Kazakov EN; Kormer AI; Chestukhin VV; Za'idenov Va; Boikina TV; Selezneva EA
    Arkh Patol; 1995; 57(6):3-7. PubMed ID: 8742178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
    Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
    Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors.
    Crespo M; Sole M; Arostegui JL; Mila J; Martorell J; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial monitoring of humoral antibody-mediated rejection of cardiac allografts by C4d staining of interstitial capillaries.
    Suggs J; Goodin J; Cruse JM; Lewis RE; Allen B; Bigler S; Moore C; Thompson R; McIntire H
    Exp Mol Pathol; 2009 Feb; 86(1):41-5. PubMed ID: 19111538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
    Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
    J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
    Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
    J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection.
    Sorrentino C; Scarinci A; D'Antuono T; Piccirilli M; Di Nicola M; Pasquale M; Di Iorio C; Di Carlo E
    J Pathol; 2006 Jul; 209(3):400-10. PubMed ID: 16583358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible NO synthase expression in endomyocardial biopsies after heart transplantation in relation to the postoperative course.
    Koch A; Burgschweiger A; Herpel E; Sack FU; Schirmacher P; Szabo GB; Karck M; Schnabel PA
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):639-43. PubMed ID: 17689088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C4d-the witness of humoral rejection.
    de Gouveia RH; Vitorino E; Ramos S; Rebocho MJ; Queirós E Melo J; Martins AP; Moura ML
    Transplant Proc; 2009 Apr; 41(3):866-7. PubMed ID: 19376374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries.
    Aita K; Yamaguchi Y; Shimizu T; Horita S; Furusawa M; Tanabe K; Fuchinoue S; Toma H
    Clin Transplant; 2004; 18 Suppl 11():7-12. PubMed ID: 15191366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [C4d: a pathogenetically relevant marker in kidney transplantation].
    Regele H
    Verh Dtsch Ges Pathol; 2004; 88():89-97. PubMed ID: 16892538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.
    Karason K; Jernås M; Hägg DA; Svensson PA
    BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early screening for antibody-mediated rejection in heart transplant recipients.
    Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
    J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy.
    Li R; Chen G; Guo H; Wang DW; Xie L; Wang SS; Wang WY; Xiong YL; Chen S
    Transplant Proc; 2006 Dec; 38(10):3263-5. PubMed ID: 17175243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients.
    Dixon V; Macauley C; Burch M; Sebire NJ
    Pediatr Transplant; 2007 May; 11(3):286-90. PubMed ID: 17430484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decay-accelerating factor expression may provide immunoprotection against antibody-mediated cardiac allograft rejection.
    González-Stawinski GV; Tan CD; Smedira NG; Starling RC; Rodríguez ER
    J Heart Lung Transplant; 2008 Apr; 27(4):357-61. PubMed ID: 18374870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.